Evidence map›Paper›PMID 33927996›Full record

Article3 Biotech2021

Novel compound heterozygous missense variants (c.G955A and c.A1822C) of

Jingliang Cheng, Qi Zhou, Jiewen Fu, Chunli Wei, Lianmei Zhang, Md Shamsuddin Sultan Khan, Hongbin Lv, Songyot Anuchapreeda, Junjiang Fu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Novel pathogenic3 Biotech · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Jingliang ChengDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, 50200 Thailand.
Qi ZhouDepartment of Ophthalmology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000 Sichuan China.
Jiewen FuKey Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, 3-319, Zhongshan Rd, Luzhou, 646000 Sichuan China.
Chunli WeiKey Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, 3-319, Zhongshan Rd, Luzhou, 646000 Sichuan China.
Lianmei ZhangDepartment of Pathology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, 223300 Jiangsu China.
Md Shamsuddin Sultan KhanKey Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, 3-319, Zhongshan Rd, Luzhou, 646000 Sichuan China.
Hongbin LvDepartment of Ophthalmology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000 Sichuan China.
Songyot AnuchapreedaDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, 50200 Thailand.
Junjiang FuDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, 50200 Thailand.ORCID 0000-0002-0708-2200
Southwest Medical University · CNAffiliated Hospital of Southwest Medical University · CNChiang Mai University · THEast Texas A&M University · USXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis pigmentosa (RP) is a rare and heterogeneous group of inherited ocular diseases. However, the relationship between

Indexed as

CACNA2D4 expressionCACNA2D4 geneCompound heterozygous mutationsNext-generation sequencingRetinitis pigmentosa

Identifiers

PMID33927996
PMCPMC8036171
OpenAlexW3156941532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.